Les antiplaquettaires en chirurgie cardiaque et non-cardiaque


Auteurs

CHASSOT PG

Ancien Privat-Docent, Maître d’enseignement et de recherche, Faculté de Biologie et de Médecine, Université de Lausanne (UNIL), CH - 1005 Lausanne 
Ancien responsable de l’Anesthésie Cardiovasculaire, Service d’Anesthésiologie, Centre  Hospitalier Universitaire Vaudois (CHUV), CH - 1011 Lausanne
Editeur en chef, responsable éditorial du Précis d'Anesthésie Cardiaque 5

 

DELABAYS A

 

Cardiologue FMH, Médecin associé, Ensemble Hospitalier de la Côte (EHC), Hôpital de Morges, CH - 1110 Morges
Médecin-adjoint au Service de Cardiologie, Centre Hospitalier Universitaire Vaudois (CHUV),  CH – 1011 Lausanne
 


SPAHN D



Professeur d’Anesthésiologie, Faculté de Médecine, Université de Zürich, CH - 8091 Zürich
Chef de Service, Institut für Anästhesiologie, Universitätspital  Zürich (USZ), CH - 8091 Zürich


© CHASSOT PG, DELABAYS A, SPAHN D  Mars 2010, dernière mise à jour Août 2019


Lectures conseillées

CAPODANNO D, ANGIOLILLO DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 2013; 128:2785-98
ESSANDOH M, DALIA AA; ALBAGHDADI M, et al. Perioperative management of dual-antiplatelet therapy in patients with new-generation drug-eluting metallic stents and bioresorbable vascular scaffolds undergoing elective noncardiac surgery. J Cardiothorac Vasc Anesth 2017; 31:1857-64
GOGARTEN W, VANDERMEULEN E, VAN AKEN H, et al. Regional anaesthesia and antithrombotic agents: recommendations of the European Society of Anaesthesiology. Eur J Anaesthesiol 2010; 27:999-1015
HALL R, MAZER CD. Antiplatelet drugs: A review of their pharmacology and management in the perioperative period. Anesth Analg 2011; 112:292-318
JEGER RV, PFISTERER ME, SEORENSEN R, et al. Tradeoff between bleeding and stent thrombosis in different dual antiplatelet therapy regimes: importance of case fatality rates and effective treatment durations. Am Heart J 2014; 168:698-705
KORTE W, CATTANEO M, CHASSOT PG, et al. Perioperative management of antiplatelet therapy in patients with coronary artery disease. Thromb Haemost 2011; 105:743-9
LAVI S, LAVI R. Perioperative managment of antiplatelet agents in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2012; 26:680-6
MONTALESCOT G, BRIEGER D, DALBY AJ, et al. Duration of dual antiplatelet therapy after coronary stenting. J Am Coll Cardiol 2015; 66:832-47
OPREA AD, POPESCU WM. ADP-receptor inhibitors in the perioperative period: the Good, the Bad and the Ugly. J Cardiothorac Vasc Anesth 2013; 27: 779-95
PALMERINI T, STONE GW. Optimal duration of dual antiplatelet therapy after drug-eluting stent inplantation: conceptual evolution based on emerging evidence. Eur Heart J 2016; 37:353-64
SMITH BB, WARNER MA, WARNER NS, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with second-generation drug-eluting stents. Anesth Analg 2019; 128:621-8
WIJEYSUNDERA DN WIJEYSUNDERA HC, YUN L, et al. Risk of elective major noncardiac surgery after coronary stent insertion. A population-based study. Circulation 2012; 126:1355.62


Recommandations

BITTL JA, BABER U, BRADLEY SM, et al. Duration of dual antiplatelet therapy: A systematic review for the 2016 ACC/AHA Guideline     focused update on duration of of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol 2016;     68:1116-39 (voir Directives: Antipl ACC/AHA 2016.pdf)
BOER C, MEESTERS MI, MILOJEVIC M, et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth 2018; 32:88-120 (voir Directives : Transfus EACTA 2018.pdf)
CAPODANNO D, ALFONSO F, LEVINE GN, et al. ACC/AHA versus ESC Guidelines on dual antiplatelet therapy. JACC guideline comparison. J Am Coll Cardiol 2018; 72:2915-31 (voir Directives: Comparaison ACC-ESC.pdf)
KOZEK-LANGENECKER SA, AHMED AB, AFSHARI A, et al. Management of severe perioperative bleeding: Guidelines from the European Society of Anaesthesiology. First update 2016. Eur J Anaesthesiol 2017; 34: 332-95 (Dir : Hémorragie ESC 2017.pdf)
LEVINE GN, BATES ER, BITTL JA, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. J Am Coll Cardiol 2016; 68:1082-115 (voir Directives Antiplaquettaires ACC/AHA 2016.pdf)
NEUMANN FJ, SOUS-UVA M, AHLSSON A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularisation. Eur Heart J 2019; 40:87-165 (voir Directives Revasc ESC EACTS 2018.pdf)
VALGIMIGLI M, BUENO H, BYRNE RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 2018; 39:213-54 (Directives: AAP ESC 2018.pdf)

Le texte en version PDF de chacune de ces recommandations se trouve sous Téléchargement / Directives CCV: Anti-plaquettaires.
 
 
 

Révision
10/17/2019 - 16:47 par